LAVA Medtech Acquisition Statistics Share Statistics LAVA Medtech Acquisition has n/a
shares outstanding. The number of shares has increased by 0%
in one year.
Shares Outstanding n/a Shares Change (YoY) 0% Shares Change (QoQ) 0% Owned by Institutions (%) n/a Shares Floating 8.71M Failed to Deliver (FTD) Shares 400 FTD / Avg. Volume 0.9%
Short Selling Information The latest short interest is 6.82K, so 0% of the outstanding
shares have been sold short.
Short Interest 6.82K Short % of Shares Out n/a Short % of Float 0.06% Short Ratio (days to cover) 1
Valuation Ratios The PE ratio is 32.52 and the forward
PE ratio is null.
LAVA Medtech Acquisition's PEG ratio is
-0.43.
PE Ratio 32.52 Forward PE n/a PS Ratio 0 Forward PS n/a PB Ratio 1.26 P/FCF Ratio -222.34 PEG Ratio -0.43
Financial Ratio History Enterprise Valuation LAVA Medtech Acquisition has an Enterprise Value (EV) of 145.32M.
EV / Sales 0 EV / EBITDA -23.36 EV / EBIT -220.58 EV / FCF -220.58
Financial Position The company has a current ratio of 0.29,
with a Debt / Equity ratio of 0.
Current Ratio 0.29 Quick Ratio 0.29 Debt / Equity 0 Debt / EBITDA n/a Debt / FCF n/a Interest Coverage 0
Financial Efficiency Return on Equity is 3.89% and Return on Invested Capital is -1.26%.
Return on Equity 3.89% Return on Assets 3.73% Return on Invested Capital -1.26% Revenue Per Employee n/a Profits Per Employee n/a Employee Count undefined Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax 304.29K Effective Tax Rate 6.33%
Stock Price Statistics The stock price has increased by -0.1% in the
last 52 weeks. The beta is 0, so LAVA Medtech Acquisition's
price volatility has been lower than the market average.
Beta 0 52-Week Price Change -0.1% 50-Day Moving Average 10.42 200-Day Moving Average 10.22 Relative Strength Index (RSI) 61.09 Average Volume (20 Days) 44,325
Income Statement
Revenue n/a Gross Profit n/a Operating Income -1.56M Net Income 4.5M EBITDA -6.22M EBIT -1.56M Earnings Per Share (EPS) 0.31
Full Income Statement Balance Sheet The company has 1.16M in cash and 0 in
debt, giving a net cash position of 1.16M.
Cash & Cash Equivalents 1.16M Total Debt n/a Net Cash n/a Retained Earnings -3.01M Total Assets 120.67M Working Capital -3.39M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -658.82K
and capital expenditures 0, giving a free cash flow of -658.82K.
Operating Cash Flow -658.82K Capital Expenditures n/a Free Cash Flow -658.82K FCF Per Share -0.05
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
